BenchSci exponentially increases the speed and quality of life-saving research by empowering scientists with the world’s most advanced biomedical artificial intelligence to run more successful experiments. Backed by F-Prime and Google’s AI fund, Gradient Ventures, BenchSci uses machine learning to diagnose pharmaceutical R&D health from hidden patterns in procurement data.
Customers receive a report on failure rates, productivity, and redundancy by department, therapeutic area, geography, and cost center. They can then address inefficiencies by deploying BenchSci's AI-Assisted Reagent Selection, which empowers scientists to select the best reagents and design criteria for their experiments. Thereafter, post-deployment reports confirm impact and ROI.
B2B
101 to 250
Series C
$94.8 M
Scaling Up
2015
Pharmaceuticals
Healthcare
Computer Software
Biotechnology
Increases Research Velocity
Increase Efficiency
IT and Security
Service
Yes
Active
Machine Learning
N/A
Software
Jan 2021
- BenchSci Listed as Best Workplace? for Startups in Canada for 2nd Consecutive Year
Mar 2019
- Sanbio B.V. Partners with BenchSci to Augment Visibility and Purchasability of Its IHC Antibodies
Software Engineer - ML/DevOps
Toronto, Ontario
R&D Engineer
Toronto, Ontario
UX Researcher
Toronto, Ontario
Senior Product Manager
Toronto, Ontario
Director of Product Design
Toronto, Ontario
AI/ML Professionals
Want to work at BenchSci?
We can introduce you to the right person at BenchSci
8
2
$66.5M
Company was founded 2015 and it took almost 7 years (Jan 2022) to raise first external round
Investors
Interested in researching BenchSci?
We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about BenchSci
Potential Customers
Interested in what they do or partnership?
Learn more about how they work
